Abstract
Osteogenic differentiation of skeletal stem cells is an integral part of bone development and homeostasis, and the perturbation of this process is one of the causes to skeletal disease. Understanding of how epigenetic events regulate skeletal stem cell differentiation is therefore of great importance. While the basic epigenetic modifications leading to bone formation are somewhat under explored, a significant amount of research has defined the regulatory roles of histone modifications in osteogenic differentiation. The orchestration of histone modifications is a requirement to establish the epigenetic status which regulates gene transcription during osteogenic differentiation of skeletal stem cells. Here we focus on the roles of histone modification during osteogenic differentiation and review studies that have advanced our knowledge in the field. Before this summary, a brief description is given regarding the up-to-date understanding of the definition of skeletal stem cells and the main mechanisms responsible for histone modifications.
Keywords: Epigenetics, histone modification, osteogenic differentiation, skeletal stems cells.
Current Stem Cell Research & Therapy
Title:Histone Modification in Osteogenic Differentiation of Skeletal Stem Cells
Volume: 10 Issue: 5
Author(s): Yin Tang, Yi Fan, Mian Wan, Xin Xu, Jing Zou, Ling Ye and Liwei Zheng
Affiliation:
Keywords: Epigenetics, histone modification, osteogenic differentiation, skeletal stems cells.
Abstract: Osteogenic differentiation of skeletal stem cells is an integral part of bone development and homeostasis, and the perturbation of this process is one of the causes to skeletal disease. Understanding of how epigenetic events regulate skeletal stem cell differentiation is therefore of great importance. While the basic epigenetic modifications leading to bone formation are somewhat under explored, a significant amount of research has defined the regulatory roles of histone modifications in osteogenic differentiation. The orchestration of histone modifications is a requirement to establish the epigenetic status which regulates gene transcription during osteogenic differentiation of skeletal stem cells. Here we focus on the roles of histone modification during osteogenic differentiation and review studies that have advanced our knowledge in the field. Before this summary, a brief description is given regarding the up-to-date understanding of the definition of skeletal stem cells and the main mechanisms responsible for histone modifications.
Export Options
About this article
Cite this article as:
Tang Yin, Fan Yi, Wan Mian, Xu Xin, Zou Jing, Ye Ling and Zheng Liwei, Histone Modification in Osteogenic Differentiation of Skeletal Stem Cells, Current Stem Cell Research & Therapy 2015; 10(5) . https://dx.doi.org/10.2174/1574888X1005150820120939
DOI https://dx.doi.org/10.2174/1574888X1005150820120939 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy A Review of HPLC Methods Used for Determining the Presence of Meloxicam
Current Pharmaceutical Analysis Gene Therapy in In Vivo Isolated Perfusion Models
Current Gene Therapy Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Current Pharmaceutical Biotechnology Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
Current Molecular Imaging (Discontinued) Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Anti-Cancer Agents in Medicinal Chemistry The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer
Combinatorial Chemistry & High Throughput Screening New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Cytotoxicity of a Vanadyl(IV) Complex with a Multidentate Oxygen Donor in Osteoblast Cell Lines in Culture
Medicinal Chemistry Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment
Current Medicinal Chemistry Assessment of Gene Transfer Using Imaging Methodology
Current Genomics Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry Application of Molecular Imaging Technologies in Antitumor Drug Development and Therapy
Current Pharmaceutical Design Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Current Drug Targets - Inflammation & Allergy Glutamine, Glucose and other Fuels for Cancer
Current Pharmaceutical Design